Betsy DeVos is arguably the most controversial figure ever nominated to lead the U.S. Department of Education. Yet in covering her nomination, many journalists have conflated valid concerns about experience, temperament and political beliefs with questionable assumptions about her religious background, argues Abram Van Engen, associate professor of English.
Chancellor Mark S. Wrighton has spoken out recently to underscore the global nature of our university community and our commitment to welcoming students, scholars, faculty and staff from all around the world. Chancellor Wrighton today shared a statement of principles building on those sentiments.
The Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship opened a facility on the Medical Campus in the Taylor Avenue Building. Register to attend the next LEAP Inventor Challenge workshops in that space Tuesday, Feb. 7.
Neil Gorsuch, President Donald Trump’s nominee to fill the vacant seat on the U.S. Supreme Court, has a strong commitment to rule of law values and is the best possible choice among the potential nominees that Trump circulated before the election, says a Supreme Court scholar at Washington University in St. Louis.
Combining a drug for rheumatoid arthritis with one that targets the chikungunya virus can eliminate the signs of chikungunya arthritis in mice in the disease’s earliest stage, according to researchers at Washington University School of Medicine in St. Louis.
A paper authored by Stephen Linderman, an MD/PhD candidate at Washington University in St. Louis, recently took first prize at the American Society of Mechanical Engineers International Mechanical Engineering Congress and Exhibition.
In response to the federal government’s to controversial immigration ban, Washington University in St. Louis sophomore Jordan Gonen launched the site CelebrateImmigrants.us, an inventory of immigrant business founders from Irish immigrant James Gamble of Procter & Gamble to South African-born Elon Musk of Tesla.
Allison A. King, MD, PhD, a highly regarded sickle cell disease researcher at Washington University School of Medicine in St. Louis, has received a six-year, $4.3 million grant from the National Institutes of Health (NIH) to further her investigations into the disease.
Audrey R. Odom John, MD, PhD, is a globally recognized malaria expert at Washington University School of Medicine in St. Louis. She runs a nine-member research lab in the Division of Infectious Diseases. The researchers hope to develop new diagnostic tests for malaria detection as well as antimalarial drugs.
The Kathryn M. Buder Center for American Indian Studies at the Brown School will tackle issues surrounding the controversial Dakota Access pipeline during the “Indigenous Rights and Environmental Justice Symposium: From Standing Rock to St. Louis” Monday, Feb. 6.
